首页> 外文会议>World biomaterials congress >SEP cross-linked porous silk fibroin/PVA scaffolds for tissue regeneration: fabrication, characterization and cyto-compatibility studies
【24h】

SEP cross-linked porous silk fibroin/PVA scaffolds for tissue regeneration: fabrication, characterization and cyto-compatibility studies

机译:用于组织再生的SEP交联多孔丝素蛋白/ PVA支架:制备,表征和细胞相容性研究

获取原文

摘要

The present study reports the development of silk fibroin/polyvinyl alcohol scaffold conjugated with soluble eggshell membrane protein (SEP) to improve the mechanical and cell supportive properties for tissue regeneration. SEP-SF/PVA scaffold has shown better surface property, desired pores (230-360 pm) interconnected network and compressive strength (247.5 ± 23.7 KPa). The existence of SEP on the scaffold surface and the structural and thermal stability were confirmed by energy-dispersive X-ray spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. In vitro cell culture study has shown superior cell supportive property compared to non-conjugated counterpart. The cyto-compatibility of SEP conjugated scaffold was further confirmed by in-vivo testing in mice model. Overall, the study demonstrates that SEP can be used as an excellent surface property enhancer for silk fibroin based scaffolds thereby make them potential artificial extracellular matrix for tissue engineering applications. Figure: SEM of cell-scaffold construct for SF/PVA (a,c,e,g) and SEP-ISF/PVA) (b,d,f,h) scaffold for day 1 (a,b), day 3 (c,d), day 7(e,f) and day 14 (g, h) with umbilical cord blood derived hMSCs.
机译:本研究报告了与可溶性蛋壳膜蛋白(SEP)偶联的丝素蛋白/聚乙烯醇支架的开发,以改善组织再生的机械和细胞支持特性。 SEP-SF / PVA支架表现出更好的表面性能,所需的孔(230-360 pm)相互连接的网络和抗压强度(247.5±23.7 KPa)。通过能量色散X射线光谱,X射线衍射,傅立叶变换红外光谱,差示扫描量热法和热重分析,证实了SEP在脚手架表面上的存在以及结构和热稳定性。体外细胞培养研究表明,与非缀合的对应物相比,其具有更好的细胞支持特性。通过在小鼠模型中的体内测试,进一步证实了SEP缀合的支架的细胞相容性。总体而言,该研究表明SEP可以用作基于丝素蛋白的支架的优异表面性能增强剂,从而使其成为组织工程应用中潜在的人工细胞外基质。图:第1天(a,b),第3天(SF,PVA(a,c,e,g)和SEP-ISF / PVA)(b,d,f,h)支架的细胞支架构建体的SEM(b,d,f,h) c,d),第7(e,f)天和第14(g,h)天使用脐带血来源的hMSC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号